Asterias Biotherapeutics to Discuss Cancer Immunotherapy Product AST-VAC2 at the World Advanced Therapies and …NasdaqAST-VAC2 is an innovative immunotherapy product that contains mature dendritic cells derived from pluripotent stem cells. These non-p… Continue reading
WIREDIs This Stem Cell Clinic Really Making Cancer Vaccines? | WIREDWIREDIn a Facebook live video, the CSO of one of the largest networks of stem cell clinics in the country touted a new, unregulated treatment.Novel stem cell therapy to be tested on lo… Continue reading
The Pharma LetterNovo Nordisk partners on stem cell-based therapiesThe Pharma LetterDanish diabetes care giant Novo Nordisk (NOV: N) today announced an increased commitment to stem cell-based therapies and an expansion of the focus on type 1 diabetes i… Continue reading
Nikkei Asian Review |
Japan approves first trials of stem cell-based heart treatment
Nikkei Asian Review TOKYO — Japan is set to host the world’s first clinical trials involving the use of induced pluripotent stem (iPS) cells to treat heart failure. A special health ministry panel on Wednesday gave Osaka University the green light to carry out the study … Japan OKs first clinical study of iPS cell-based heart treatmentThe Japan Times |
|
SOSV’s Bill Liao: ‘Synthetic biology is as important as the discovery of fire’
Siliconrepublic.com Well, SOSV has done it again and according to a recent analysis by life sciences analyst Calvin Schmidt, the Cork and San Francisco venture firm is still the world’s leading investor in synthetic biology, surpassing even Microsoft founder and former … |
|
Gene Therapy Market, 2030
GlobeNewswire (press release) The Gene Therapy Market (2nd Edition), 2018-2030′ report provides an extensive study on the current market landscape of gene therapies, with a prime focus on gene augmentation based therapies and oncolytic viral therapies, featuring an elaborate … |
|
Gene Therapy Market, 2030
GlobeNewswire (press release) The Gene Therapy Market (2nd Edition), 2018-2030′ report provides an extensive study on the current market landscape of gene therapies, with a prime focus on gene augmentation based therapies and oncolytic viral therapies, featuring an elaborate … |